Sexual Health News - HIV
HIV study given accolades by medical journal
Earlier this year, researchers at the University of North Carolina at Chapel Hill's Institute for Global Health and Infectious Diseases discovered that beginning antiretroviral therapy on HIV positive individuals while their immune system is still strong was much more effective at preventing the spread of the disease than administering the drugs after the immune system has weakened.
Now, the authors of the journal Science are calling the discovery the 2011 Breakthrough of the Year.
The researchers had planned to end their trial in 2015, but promising results that occurred in May this year spurred them to end it early. They discovered that there was just one case of HIV infection among individuals who were given early antiretroviral treatment, compared to 28 in a control group.
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, said that the treatment may be especially significant when combined with other anti-HIV efforts.
"Scale-up of these proven prevention methods combined with continued research toward a preventive HIV vaccine and female-controlled HIV prevention tools places us on a path to achieving something previously unimaginable: an AIDS-free generation," said Fauci.